Priya PatelBone Biologics has appointed Robert E. Gagnon as a member of its board of directors. Gagnon is currently the CFO of clinical stage company Remix Therapeutics. Gagnon has more than 20 years of experience in finance and business operations in the life sciences sector. His experience includes roles as Chief Business Officer and Chief Financial Officer at Verastem Oncology, Chief Financial Officer at Harvard Bioscience, and Executive Vice President, Chief Financial Officer, and Treasurer at Clean Harbors. Gagnon holds an MBA from the MIT Sloan School of Management and a BA in Accounting from Bentley College.
Introducing Robert E. Gagnon: A Financial Maestro on Bone Biologics’ Board
Latest from News
Australian Fintech Stables launches money transfers between Aus and Philippines.
TLDR: Stables has launched international remittances between Australia and the Philippines. Users can now send Australian Dollars or Philippine Pesos using stablecoins. Stables, an
Brazilian FinTechs struggle with rising delinquency rates, feeling the heat.
TLDR: Delinquency rates on unsecured loans offered by Brazilian FinTech firms like Open Co, Nexoos, and Gyra+ have exceeded 60%, impacting the asset-backed credit
Goldman Sachs-backed startup mulls sale amid Fintech slowdown, sources report
TLDR: Deserve, a credit card software company valued at $500 million, is considering selling itself amid a fintech slowdown. The company, backed by high-profile
ICBA ThinkTECH Showcase: The Future of Fintech Unveiled
TLDR: ICBA hosted the ThinkTECH Showcase during its national convention, highlighting fintech solutions for community banks. Ten weeks of intense discovery and refinement culminated
Revolut & Sui: Elevating Knowledge with Blockchain Education.
TLDR: Revolut and Sui have partnered to launch a new blockchain education tool called the Learn programme. This collaboration aims to educate Revolut’s user